Galarowicz Bartlomej, Jach Robert, Kidzierska Jolanta, Dyduch Grzegorz, Zajac Krzysztof, Pityński Kazimierz, Banaś Tomasz, Huras Hubert, Streb Joanna, Dulińska-Litewka Joanna, Hosiawa Violetta, Juszczak Magdalena, Milewicz Tomasz
Jagiellonian University, Medical College, Department of Gynecology and Oncology, Krakow, Poland.
Przegl Lek. 2012;69(9):651-7.
The aim of this paper is the evaluation of colposcopy and mRNA E6/E7 HPV detection--as the marker of persistent human papilloma virus (HPV) infection in the triage of abnormal Pap smears and in the assessment of cervical intraepithelial neoplasia progression risk. The clinical material consisted of 85 women, participating the national cervical cancer screening in the period of April 2010, and October 2010, reffered to the Outpatient Clinic of Gynecologic Oncology and Female Genital Tract Neoplasms Prophylaxy of the Jagiellonian University Medical College in Krakow, Poland. All subjects were offered gynecological evaluation, Pap smear, colposcopy, DNA HPV (Hybrid Capture2, Qiagen) and mRNA E6/E7 testing (NulciSens, Biomerieux). In case of positive tests colposcopically directed cervical biopsy with histopathologic evaluation were performed.
The presence of mRNA E6/E7 HPV transcripts correlated with high grade squamous intraepithelial lesions, statistically significantly. There was statistically difference between colposcopic, histologic concordance comparing to mRNA E6/E7 HPV colposcopic histologic concordance (p < 0.001).
The presence of mRNA E6/E7 HR HPV may be assumed as specific marker of high grade cervical lesions. The combination of mRNA E6/E7 HR HPV ewith colposcopic evaluation increases the colposcopy concordanece with final histologic findings.
本文旨在评估阴道镜检查和mRNA E6/E7人乳头瘤病毒(HPV)检测,将其作为异常巴氏涂片分流及评估宫颈上皮内瘤变进展风险中持续性HPV感染的标志物。临床资料包括2010年4月至10月期间参与波兰克拉科夫雅盖隆大学医学院妇科肿瘤与女性生殖道肿瘤预防门诊的85名女性,她们参加了全国宫颈癌筛查。所有受试者均接受了妇科评估、巴氏涂片、阴道镜检查、DNA HPV(杂交捕获2代,Qiagen公司)和mRNA E6/E7检测(NulciSens,生物梅里埃公司)。检测呈阳性者进行阴道镜引导下宫颈活检及组织病理学评估。
mRNA E6/E7 HPV转录本的存在与高级别鳞状上皮内病变相关,具有统计学显著性。与mRNA E6/E7 HPV阴道镜组织学一致性相比,阴道镜与组织学一致性存在统计学差异(p<0.001)。
mRNA E6/E7高危型HPV的存在可被视为高级别宫颈病变的特异性标志物。mRNA E6/E7高危型HPV与阴道镜评估相结合可提高阴道镜与最终组织学结果的一致性。